ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
nasopharyngeal-carcinoma
nasopharyngeal carcinoma, recurrent or metastatic, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 873281
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.